Continue to Site

FDA clears Quantum Surgical’s robot-assisted tumor ablation tech

March 22, 2022 By Sean Whooley

[Image from Quantum Surgical]

Quantum Surgical announced today that it received FDA 510(k) clearance for its Epione interventional oncology robotics platform.

Montpellier, France–based Quantum Surgical designed Epione, a robot-assisted system, to plan, target, deliver and confirm tumor ablation in minimally invasive liver cancer treatment.

Get the full story at our sister site, MassDevice.

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.